Science News

... from universities, journals, and other research organizations

Breakdown Of Penicillin By Resistant Bacteria Elucidated

ScienceDaily (Mar. 31, 2000) — Almost as soon as penicillin was discovered, more than 70 years ago, certain bacteria had learned how to resist this common antibiotic. These resistant bacteria make beta-lactamase, an enzyme that quickly breaks down penicillin. Now, seven decades later, scientists at the University of Chicago led by Marvin W. Makinen, Ph.D., professor of biochemistry & molecular biology, have discovered exactly how b-lactamases deactivate penicillin.

Their findings, published in the March 28 issue of the journal Proceedings of the National Academy of Sciences, could lead to improved antibiotic design.

"While we cannot predict how these results may lead to improved antibiotics, the chemical principles governing the reactivity of penicillin that we have found are fundamental for designing compounds of pharmacologic importance," says Makinen.

Penicillin-resistant organisms are currently among the most important sources of hospital-acquired infections. Some bacteria have acquired the genetic blueprints for producing a very effective zinc-containing b-lactamase enzyme that is being encountered with increasing frequency in hospitals and in the community.

Makinen and colleagues used analysis of electrostatic forces between individual atoms of the penicillin and b-lactamase enzyme and computational simulation of their interactions. They concluded that b-lactamase attacks penicillin in a way different than previously thought.

An intact penicillin molecule contains a characteristic segment known as the b-lactam ring. Destruction of one crucial bond in the ring causes the penicillin to become deactivated. But instead of the b-lactamase breaking the bond by attacking a key carbon atom that forms part of the bond, b-lactamase destroys the bond by first adding a single proton to it to destabilize it and make it easier to break.

"Knowing more accurately the chemical and physical basis of the interaction of penicillin and b-lacatamses will help in structure-based drug design," Makinen says.

Recommend this story on Facebook, Twitter,
and Google +1:

Other bookmarking and sharing tools:

| More

Story Source:

The above story is reprinted from materials provided by University Of Chicago Medical Center.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


APA

MLA

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Search ScienceDaily

Number of stories in archives: 114,804

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.

 
  more breaking science news

Social Networks


Recommend this story on Facebook, Twitter,
and Google +1:
Other bookmarking and sharing tools:
| More

Breaking News

... from NewsDaily.com

In Other News ...

Copyright Reuters 2008. See Restrictions.

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

 
Post this page to your favorite social bookmarking site:
close
Include this item in your blog or web site:
close
Cite this article in your essay, paper, or report:
close
Email this page's link to a friend or colleague:
close